Leveraging Natural Capital: Costa Rica Biomaterials Hub

The project's objective is to develop a biomaterials research, development, and innovation hub that will provide technology services to companies based in Costa Rica, with the potential to later extend its reach to other Latin America and Caribbean countries. The hub will initially focus on such high value-added segments as pharmaceuticals and medical devices, to help make Costa Rica more competitive in the high-tech arena.

Project Detail

Country

Costa Rica

Project Number

CR-T1210

Approval Date

December 9, 2019

Project Status

Closed

Project Type

Technical Cooperation

Sector

SCIENCE AND TECHNOLOGY

Subsector

R&D AND INNOVATION FUNDING

Lending Instrument

Multilateral Investment Fund Instrument

Lending Instrument Code

MIF

Modality

Facility Type

Environmental and Social Impact Category (ESIC)

Category C: Likely to cause minimal or no negative environmental and associated social impacts

Total Cost

USD 2,015,000.00

Country Counterpart Financing

USD 1,152,500.00

Original Amount Approved

USD 862,500.00

Financial Information

Operation Number	Lending Type	Reporting Currency	Reporting Date	Signed Date	Fund	Financial Instrument
ATN/ME-17791-CR	Non-Sovereign Guaranteed	USD - United States Dollar	Oct. 28, 2025	Jun. 3, 2020	Multilateral Investment Fund II (MIF) -	Nonreimbursable

Operation Number

ATN/ME-17791-CR

Lending Type: Non-Sovereign Guaranteed
Reporting Currency: USD - United States Dollar
Reporting Date: Oct. 28, 2025
Signed Date: Jun. 3, 2020
Fund: Multilateral Investment Fund II (MIF) -
Financial Instrument: Nonreimbursable

Can’t find a document? Request information

Implementation Phase

https://www.iadb.org/document.cfm?id=EZIDB0000199-1436017807-183